EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia

Muhammad Yasir, Hessa A Al-Sharif, Tagreed Al-Subhi, Anees A Sindi, Diyaa H Bokhary, Mai M El-Daly, Bandar Alosaimi, Maaweya E Hamed, Asad Mustafa Karim, Ahmed M Hassan, Mustafa M AlShawdari, Maha Alawi und 2 weitere

Journal of Infection and Public Health · 2023

DOI: 10.1016/j.jiph.2023.03.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2023. Verfasst von Muhammad Yasir und 13 weiteren Autor:innen. Beteiligte Einrichtung: Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Labor…. Hauptthemen laut MEDLINE: COVID-19, Coinfection, Microbiota, Respiratory Tract Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Infection with SARS-CoV-2 may perturb normal microbiota, leading to secondary infections that can complicate the viral disease. The aim of this study was to probe the alteration of nasopharyngeal (NP) microbiota in the context of SARS-CoV-2 infection and obesity and to identify other respiratory pathogens among COVID-19 cases that may affect patients' health. METHODS: A total of 107 NP swabs, including 22 from control subjects and 85 from COVID-19 patients, were processed for 6S amplicon sequencing. The respiratory pathogens causing secondary infections were identified by RT-PCR assay, using a kit that contained specific primers and probes combinations to amplify 33 known respiratory pathogens. RESULTS: No significant (p > 0.05) difference was observed in the alpha and beta diversity analysis, but specific taxa differed significantly between the control and COVID-19 patient groups. Genera of Sphingomonas, Kurthia, Microbacterium, Methylobacterium, Brevibacillus, Bacillus, Acinetobacter, Lactococcus, and Haemophilus was significantly abundant (p < 0.05) in COVID-19 patients compared with a healthy control group. Staphylococcus was found in relatively high abundance (35.7 %) in the COVID-19 patient groups, mainly those treated with antibiotics. A relatively high percentage of Streptococcus was detected in COVID-19 patient groups with obesity or other comorbidities. Respiratory pathogens, including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Salmonella species, along with Pneumocystis jirovecii fungal species were detected by RT-PCR mainly in the COVID-19 patients. Klebsiella pneumoniae was commonly found in most of the samples from the control and COVID-19 patients. Four COVID-19 patients had viral coinfections with human adenovirus, human rhinovirus, enterovirus, and human parainfluenza virus 1. CONCLUSIONS: Overall, no substantial difference was observed in the predominant NP bacterial community, but specific taxa were significantly changed between the healthy control and COVID-19 patients. Comparatively, an increased number of respiratory pathogens were identified in COVID-19 patients, and NP colonization by K. pneumoniae was probably occurring in the local population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19CoinfectionMicrobiotaRespiratory Tract InfectionsHumansSaudi ArabiaSARS-CoV-2NasopharynxKlebsiella pneumoniaeObesity

Stichwörter der Autor:innen

16S ampliconCOVID-19Nasopharyngeal microbiomeSaudi ArabiaSecondary infection

Autor:innen und Institutionen

  • Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz Un…
  • Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Department of Anesthesia and Critical Care, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Pulmonary & Critical Care Consultant, International Medical Center, Jeddah 21589, Saudi Arabia.
  • Emergency Medicine Department, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, the Republic of Korea.

Zitieren

APA

Yasir, M., Al-Sharif, H. A., Al-Subhi, T., Sindi, A. A., Bokhary, D. H., El-Daly, M. M., Alosaimi, B., Hamed, M. E., Karim, A. M., Hassan, A. M., AlShawdari, M. M., Alawi, M., El-Kafrawy, S. A., & Azhar, E. I. (2023). Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2023.03.001

Vancouver

Yasir M, Al-Sharif HA, Al-Subhi T, Sindi AA, Bokhary DH, El-Daly MM, et al. Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia. Journal of Infection and Public Health. 2023. doi:10.1016/j.jiph.2023.03.001

BibTeX
@article{Yasir2023,
  author = {Yasir, Muhammad and Al-Sharif, Hessa A and Al-Subhi, Tagreed and Sindi, Anees A and Bokhary, Diyaa H and El-Daly, Mai M and Alosaimi, Bandar and Hamed, Maaweya E and Karim, Asad Mustafa and Hassan, Ahmed M and AlShawdari, Mustafa M and Alawi, Maha and El-Kafrawy, Sherif A and Azhar, Esam I},
  title = {Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia},
  journal = {Journal of Infection and Public Health},
  year = {2023},
  doi = {10.1016/j.jiph.2023.03.001}
}
Kostenlos starten →